Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Mitra, A ^a,b   MacIntyre, D A ^a   Lee, Y S ^a   Smith, A ^c   Marchesi, J R ^c   Lehne, B ^a   Bhatia, R ^d   Lyons, D ^e   Paraskevaidis, E ^f   Li, J V ^c   Holmes, E ^c   Nicholson, J K ^c   Bennett, P R ^a,b   Kyrgiou, M ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^f UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; RNA 16S; VIRUS DNA;

ADULT; BIODIVERSITY; COHORT ANALYSIS; DISEASE COURSE; FEMALE; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; LACTOBACILLUS; METABOLISM; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; PAPILLOMAVIRIDAE; PATHOLOGY; PEPTOSTREPTOCOCCUS; SEVERITY OF ILLNESS INDEX; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VAGINA; VIROLOGY; YOUNG ADULT;

ADULT; BIODIVERSITY; BIOMARKERS; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; LACTOBACILLUS; MICROBIOTA; MIDDLE AGED; PAPILLOMAVIRIDAE; PEPTOSTREPTOCOCCUS; RNA, RIBOSOMAL, 16S; SEVERITY OF ILLNESS INDEX; UTERINE CERVICAL NEOPLASMS; VAGINA; YOUNG ADULT;

EID: 84947555858     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16865     Document Type: Article

References (44)

1. Munoz, N. Human papillomavirus and cancer: the epidemiological evidence. J. Clin. Virol. 19, 1-5 (2000).
2. Myers, E. R., McCrory, D. C., Nanda, K., Bastian, L. & Matchar, D. B. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am. J. Epidemiol. 151, 1158-1171 (2000).
3. Richardson, H. et al. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol. Biomarkers Prev. 12, 485-490 (2003).
4. Martin, D. H. The microbiota of the vagina and its influence on womens health and disease. Am. J. Med. Sci. 343, 2-9, doi: 10.1097/MAJ.0b013e31823ea228 (2012).
5. Boskey, E. R., Cone, R. A., Whaley, K. J. & Moench, T. R. Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum. Reprod. 16, 1809-1813 (2001).
6. McMillan, A. et al. Disruption of urogenital biofilms by lactobacilli. Colloids Surf B Biointerfaces 86, 58-64, doi: 10.1016/j. colsurfb.2011.03.016 (2011).
7. Boris, S. & Barbes, C. Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes Infect 2, 543-546 (2000).
8. Aroutcheva, A. et al. Defense factors of vaginal lactobacilli. Am. J. Obstet. Gynecol. 185, 375-379, doi: 10.1067/mob.2001.115867 (2001).
9. Ocana, V. S., Pesce De Ruiz Holgado, A. A. & Nader-Macias, M. E. Characterization of a bacteriocin-like substance produced by a vaginal Lactobacillus salivarius strain. Appl. Environ. Microbiol. 65, 5631-5635 (1999).
10. Ravel, J. et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA 108 Suppl 1, 4680-4687, doi: 10.1073/ pnas.1002611107 (2011).
11. Gajer, P. et al. Temporal dynamics of the human vaginal microbiota. Sci. Transl. Med. 4, 132ra152, doi: 10.1126/scitranslmed.3003605 (2012).
12. MacIntyre, D. A. et al. The vaginal microbiome during pregnancy and the postpartum period in a European population. Sci. Rep. 5, 8988, doi: 10.1038/srep08988 (2015).
13. Romero, R. et al. The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome 2, 4, doi: 10.1186/2049-2618-2-4 (2014).
14. Brotman, R. M. et al. Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J. Infect. Dis. 202, 1907-1915, doi: 10.1086/657320 (2010).
15. Atashili, J., Poole, C., Ndumbe, P. M., Adimora, A. A. & Smith, J. S. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 22, 1493-1501, doi: 10.1097/QAD.0b013e3283021a37 (2008).
16. Racicot, K. et al. Viral infection of the pregnant cervix predisposes to ascending bacterial infection. J. Immunol. 191, 934-941, doi: 10.4049/jimmunol.1300661 (2013).
17. Guo, Y., You, K., Qiao, J., Zhao, Y. & Geng, L. Bacterial vaginosis is conducive to the persistence of HPV infection. Int. J. STD AIDS 23, 581-584 (2012).
18. King, C. C. et al. Bacterial vaginosis and the natural history of human papillomavirus. Infect. Dis. Obstet. Gynecol. 2011, 319460, doi: 10.1155/2011/319460 (2011).
19. Gillet, E. et al. Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis. BMC Infect. Dis. 11, 10, doi: 10.1186/1471-2334-11-10 (2011).
20. Gillet, E. et al. Association between bacterial vaginosis and cervical intraepithelial neoplasia: systematic review and metaanalysis. PLoS One 7, e45201, doi: 10.1371/journal.pone.0045201 (2012).
21. Lee, J. E. et al. Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort. PLoS One 8, e63514, doi: 10.1371/journal.pone.0063514 (2013).
22. Brotman, R. M. et al. Interplay Between the Temporal Dynamics of the Vaginal Microbiota and Human Papillomavirus Detection. J. Infect. Dis. doi: 10.1093/infdis/jiu330 (2014).
23. Marchesi, J. R. et al. Towards the human colorectal cancer microbiome. PLoS One 6, e20447, doi: 10.1371/journal.pone.0020447 (2011).
24. Kostic, A. D. et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14, 207-215, doi: 10.1016/j.chom.2013.07.007 (2013).
25. Kostic, A. D. et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292-298, doi: 10.1101/gr.126573.111 (2012).
26. Viaud, S. et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342, 971-976, doi: 10.1126/science.1240537 (2013).
27. Hillier, S. L. & Lau, R. J. Vaginal microflora in postmenopausal women who have not received estrogen replacement therapy. Clin. Infect. Dis. 25 Suppl 2, S123-126 (1997).
28. Woodworth, C. D. HPV innate immunity. Front. Biosci. 7, d2058-2071 (2002).
29. Garcea, G., Dennison, A. R., Steward, W. P. & Berry, D. P. Role of inflammation in pancreatic carcinogenesis and the implications for future therapy. Pancreatology 5, 514-529, doi: 10.1159/000087493 (2005).
30. Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860-867, doi: 10.1038/nature01322 (2002).
31. Scott, M., Stites, D. P. & Moscicki, A. B. Th1 cytokine patterns in cervical human papillomavirus infection. Clin. Diagn. Lab. Immunol. 6, 751-755 (1999).
32. Klebanoff, S. J. & Coombs, R. W. Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission. J. Exp. Med. 174, 289-292 (1991).
33. Klebanoff, S. J., Hillier, S. L., Eschenbach, D. A. & Waltersdorph, A. M. Control of the microbial flora of the vagina by H2O2- generating lactobacilli. J. Infect. Dis. 164, 94-100 (1991).
34. Clark, R. A. & Klebanoff, S. J. Role of the myeloperoxidase-H2O2-halide system in concanavalin A-induced tumor cell killing by human neutrophils. J. Immunol. 122, 2605-2610 (1979).
35. Motevaseli, E. et al. Normal and tumour cervical cells respond differently to vaginal lactobacilli, independent of pH and lactate. J. Med. Microbiol. 62, 1065-1072, doi: 10.1099/jmm.0.057521-0 (2013).
36. Brotman, R. M. et al. Association between cigarette smoking and the vaginal microbiota: a pilot study. BMC Infect. Dis. 14, 471, doi: 10.1186/1471-2334-14-471 (2014).
37. Kyrgiou, M. et al. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 367, 489-498, doi: 10.1016/S0140-6736(06)68181-6 (2006).
38. Kyrgiou, M. et al. Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: systematic review and meta-analysis. BMJ 349, g6192, doi: 10.1136/bmj.g6192 (2014).
39. Vujic, G., Jajac Knez, A., Despot Stefanovic, V. & Kuzmic Vrbanovic, V. Efficacy of orally applied probiotic capsules for bacterial vaginosis and other vaginal infections: a double-blind, randomized, placebo-controlled study. Eur. J. Obstet. Gynecol. Reprod. Biol. 168, 75-79, doi: 10.1016/j.ejogrb.2012.12.031 (2013).
40. Hesselink, A. T. et al. Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening. J. Clin. Microbiol. 51, 2409-2410, doi: 10.1128/JCM.00633-13 (2013).
41. Kozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K. & Schloss, P. D. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl. Environ. Microbiol. 79, 5112-5120, doi: 10.1128/AEM.01043-13 (2013).
42. Wang, Q., Garrity, G. M., Tiedje, J. M. & Cole, J. R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73, 5261-5267, doi: 10.1128/AEM.00062-07 (2007).
43. Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460-2461, doi: 10.1093/ bioinformatics/btq461 (2010).
44. Parks, D. H. & Beiko, R. G. Identifying biologically relevant differences between metagenomic communities. Bioinformatics 26, 715-721, doi: 10.1093/bioinformatics/btq041 (2010).